AstarZeneca gets OK for expanded Crestor use
The Associated PressOriginally published: February 09. 2010 3:01AM
Last modified: February 11. 2010 7:18AM
WASHINGTON — Federal regulators have granted AstraZeneca approval to market its cholesterol pill Crestor as a preventive measure against heart attack and stroke in patients with healthy cholesterol levels.
The Food and Drug Administration's decision will allow the company to promote Crestor to millions of U.S. patients who traditionally have not been candidates for cholesterol-lowering drugs.
The agency posted a briefing on the approval to its Web site late Monday.
The Anglo-Swedish drugmaker justified the new use with a much-heralded 2008 study, showing Crestor reduced heart attack, stroke and other problems by 44 percent in patients with normal cholesterol and slight heart disease risks.
© 2010 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
The Food and Drug Administration's decision will allow the company to promote Crestor to millions of U.S. patients who traditionally have not been candidates for cholesterol-lowering drugs.
The agency posted a briefing on the approval to its Web site late Monday.
The Anglo-Swedish drugmaker justified the new use with a much-heralded 2008 study, showing Crestor reduced heart attack, stroke and other problems by 44 percent in patients with normal cholesterol and slight heart disease risks.
© 2010 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
The agency posted a briefing on the approval to its Web site late Monday.
The Anglo-Swedish drugmaker justified the new use with a much-heralded 2008 study, showing Crestor reduced heart attack, stroke and other problems by 44 percent in patients with normal cholesterol and slight heart disease risks.
© 2010 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
The Anglo-Swedish drugmaker justified the new use with a much-heralded 2008 study, showing Crestor reduced heart attack, stroke and other problems by 44 percent in patients with normal cholesterol and slight heart disease risks.
© 2010 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
This story was edited for presentation on the Web. Additional information and details are available for subscribers only. If you want every word of Blount County's best news and information source you can get home delivery and e-edition subscriptions here. Nobody knows Blount better than The Daily Times, your hometown newspaper for 125 years and counting.